Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 5—May 2008

Perspective

Scale-up of Multidrug-Resistant Tuberculosis Laboratory Services, Peru

Sonya S. Shin*Comments to Author , Martin Yagui†, Luis Ascencios†, Gloria Yale‡, Carmen Suarez‡, Neyda Quispe†, Cesar Bonilla‡, Joaquin Blaya§, Allison Taylor¶, Carmen Contreras#, and Peter Cegielski¶
Author affiliations: *Brigham and Women’s Hospital, Boston, Massachusetts, USA; †Instituto Nacional de Salud, Lima, Peru; ‡Programa de Control de Tuberculosis, Lima, Peru; §Partners in Health, Boston, Massachusetts, USA; ¶Centers for Disease Control and Prevention, Atlanta, Georgia, USA; #Socios en Salud, Lima, Peru;

Main Article

Table 2

Baseline laboratory capacity for diagnosis of tuberculosis, Peru, 1996–2000*

Activity Validation or quality control procedures No. establishments No. performed/year
Smear microscopy Quality control of all AFB+ and 10% of AFB– results each trimester at regional level of laboratories 987 1,164,198
Mycobacterial culture Once a year, quality control of media culture 57 48,346
Drug susceptibility testing External quality control in INPPAZ 1 1,045

*AFB, acid-fast bacilli; INPPAZ, Instituto Panamericano de Protección de Alimentos y Zoonosis.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO